Paul J Clancy insider trades
Open-market stock purchases and sales by Paul J Clancy, Director at Incyte Corp, from SEC Form 4 filings since Feb 12, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 30, 2026 | INCY Incyte Corp | Bought (not open market) | $24.6K |
| Jun 30, 2026 | INCY Incyte Corp | Bought (not open market) | $28.6K |
| Jun 17, 2026 | SION Sionna Therapeutics, Inc | Bought (not open market) | — |
| Jun 8, 2026 | INCY Incyte Corp | Bought (not open market) | — |
| Jun 8, 2026 | INCY Incyte Corp | Bought (not open market) | — |
| May 19, 2026 | INCY Incyte Corp | Sold | $1.4M |
| May 19, 2026 | INCY Incyte Corp | Bought (not open market) | — |
| Mar 31, 2026 | INCY Incyte Corp | Bought (not open market) | $24.9K |
| Mar 23, 2026 | EXAS Exact Sciences Corp | Sold (not open market) | — |
| Mar 23, 2026 | EXAS Exact Sciences Corp | Sold (not open market) | — |
| Dec 31, 2025 | INCY Incyte Corp | Bought (not open market) | $23.8K |
Companies traded
- INCY Incyte Corp: 1 sale, last Sep 30, 2026
- SION Sionna Therapeutics, Inc: other filings, last Jun 17, 2026
- EXAS Exact Sciences Corp: other filings, last Mar 23, 2026
- XLO Xilio Therapeutics, Inc: other filings, last Jun 11, 2025
- AGIO Agios Pharmaceuticals, Inc: other filings, last Jun 21, 2022
- ALXN Alexion Pharmaceuticals, Inc: 2 sales, last Jul 11, 2019
- BIIB Biogen Inc: 43 sales, last Apr 25, 2017